RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Boehringer Ingelheim Venture Fund
B

Boehringer Ingelheim Venture Fund portfolio

Boehringer Ingelheim Venture Fund has 9 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Corporate venture.
Portfolio on Recent Funding: 9.
Deals, last 12 months: 2.
Rounds led: 5 of 14.
Capital in their rounds: $431.01M.
Latest deal: SRTD Biotech · Nov 9, 2026.
About this page

It is a corporate venture investor based in Ingelheim am Rhein, DE, founded in 2010. It led 5 of the 14 rounds it joined. Its most recent investment on record is SRTD Biotech's $35.26M Seed round in November 2026, which it led, alongside HTGF, NRW.BANK, Anobis Asset and 2 others. By category, its portfolio leans toward Health and bio (9) and Education (2). It has co-invested with HTGF, IBB Ventures and Xora Innovation, most often HTGF (4 rounds).

About Boehringer Ingelheim Venture Fund

Firm type: Corporate venture.
Headquarters: Ingelheim am Rhein, DE.
Founded: 2010.
Stages: Seed, Series A, Series B, Series C, Growth.
Sectors: Biotech, Digital Health, Healthtech, Medical Devices.

What Boehringer Ingelheim Venture Fund invests in

Boehringer Ingelheim Venture Fund recent investments

CompanyRoundDateAlongside
SSRTD BiotechSeed · $35.26M · leadHTGF, NRW.BANK (lead), Anobis Asset +2
CCloverleaf BioSeed · $33M4BIO Capital (lead), AbbVie, BrightEdge - American Cancer Society +3
NNuevocorSeries B+ · $45MAngelini Ventures (lead), Highlight Capital, EDBI +4
BBrainomixSeries B+ · $18.16M · leadParkwalk Advisors (lead), Hostplus, LifeSci Capital
AAignosticsSeries B+ · $34MHTGF, Wellington Management, Carma Fund +2
RRgenta TherapeuticsSeries A · $52MLilly Asia Ventures, CICC (lead), Kaitai Capital +6
AAignosticsSeries A · $13.98MHTGF, Wellington Management (lead), IBB Ventures +1
BBrainomixSeries B+ · $21.2M · leadParkwalk Advisors (lead), Tencent, Oxford University Innovation

How Boehringer Ingelheim Venture Fund invests

StageDealsCapital in rounds
Series B+ 5 36%$156.77M
Series A 5 36%$194.98M
Seed 4 29%$79.26M
YearDealsCapital in rounds
2016 1 7%$27M
2018 1 7%$5M
2020 3 21%$122.41M
2021 2 14%$45.2M
2022 2 14%$65.98M
2024 1 7%$34M
2025 2 14%$63.16M
2026 2 14%$68.26M

Boehringer Ingelheim Venture Fund portfolio companies

CompanyRound with Boehringer Ingelheim Venture FundTotal raisedLatest raise
SSRTD Biotech
Health and bio
Seed · $35.26M · lead$35.26MNov 9, 2026
Seed
CCloverleaf Bio
Health and bio
Seed · $33M$33MSep 8, 2026
Seed
NNuevocor
Health and bio
Series B+ · $45M$69MMay 6, 2025
Series B+
BBrainomix
Health and bio
Series B+ · $18.16M · lead$64.76MFeb 24, 2026
Series B+
AAignostics
Health and bio
Series B+ · $34M$53.98MOct 29, 2024
Series B+
RRgenta Therapeutics
Health and bio
Series A · $52M$52MNov 3, 2026
Series B+
TT-Knife
Health and bio
Series A · $78M$188MAug 2, 2021
Series B+
EeTheRNA Immunotherapies
Health and bio
Series B+ · $38.41M$104.41MAug 24, 2022
Series B+
WWellth
Fintech
Seed · $5M$73MSep 15, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 14 rounds on Recent Funding that name Boehringer Ingelheim Venture Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Boehringer Ingelheim Venture Fund, which is a subset of its real portfolio. API: /api/v1/investors/boehringer-ingelheim-venture-fund (get a free API key). More: the most active VC firms and new venture capital funds.